Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950124-04-000870
Filing Date
2004-03-12
Accepted
2004-03-12 14:41:31
Documents
9
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR THE PERIOD ENDED 12/31/2003 v96728e10vk.htm 10-K 525069
3 EXHIBIT 10.17 v96728exv10w17.txt EX-10.17 17466
4 EXHIBIT 10.18 v96728exv10w18.txt EX-10.18 17154
5 EXHIBIT 10.19 v96728exv10w19.txt EX-10.19 17264
6 EXHIBIT 23.1 v96728exv23w1.txt EX-23.1 1181
7 EXHIBIT 31.1 v96728exv31w1.txt EX-31.1 3571
8 EXHIBIT 31.2 v96728exv31w2.txt EX-31.2 3540
9 EXHIBIT 32.1 v96728exv32w1.txt EX-32.1 1213
10 EXHIBIT 32.2 v96728exv32w2.txt EX-32.2 1178
  Complete submission text file 0000950124-04-000870.txt   590129
Mailing Address 22026 20TH AVENUE SE, SUITE 102 BOTHELL WA 98021
Business Address 22026 2OTH AVE SE STE 102 BOTHELL WA 98021 2064879500
SONUS PHARMACEUTICALS INC (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21243 | Film No.: 04665722
SIC: 2835 In Vitro & In Vivo Diagnostic Substances